1. Zero-residual syringe als verpakkingsmateriaal voor bevacizumab als intravitreale injectie - Antwoord van de auteurs

   Jacobs, M. S., Hemminga, W. L., Woerdenbag, H. J., Bouma, M. & Moes, J. R., 20-Jan-2017, In : Pharmaceutisch Weekblad. 152, 3, 1 p.

   Research output: Contribution to journal › Letter › Academic › peer-review

2. Atrial Fibrillation in Africa-An Underreported and Unrecognized Risk Factor for Stroke: A Systematic Review

   Jacobs, M. S., van Hulst, M., Adeoye, A. M., Tieleman, R. G., Postma, M. J. & Owolabi, M. O., Sep-2019, In : Global heart. 14, 3, p. 269-279

   Research output: Contribution to journal › Review article › Academic › peer-review

3. To Bridge or Not to Bridge: Modelling Periprocedural Anticoagulation Management

   van der Pol, S., Jacobs, M., Meijer, K., Piersma-Wichers, M. G., Tieleman, RG., Postma, M. & van Hulst, M., 3-Aug-2018, p. E417. 1 p.

   Research output: Contribution to conference › Poster › Academic

4. Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!

   Jacobs, M. S. & Tieleman, R. G., Jun-2018, In : Netherlands Heart Hournal. 26, 6, p. 334-340 7 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

5. Letter responding to Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart RhythmSociety (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Societad Latinoamericana de Estimulation Cardiaca y Electrofisiologia (SOLAECE)

   Jacobs, M. S., van Hulst, M. & Tieleman, R. G., 1-May-2018, In : Europace. 20, 5, p. 893-893 1 p.

   Research output: Contribution to journal › Letter › Academic › peer-review

View all (11) »